Cytochrome P450 2E1 (CYP2E1)

CPE1; CYPIIE1; P450-J; P450C2E; 4-nitrophenol 2-hydroxylase; Cytochrome P450 Family 2 Subfamily E 1; Cytochrome P450,Subfamily IIE(Ethanol-Inducible)Polypeptide 1

SPN	V824
HGNC	2631
MGI	88607
PubMed	12883487
RGD	2475
UniProt	P05181
Wiki	CYP2E1

Cytochrome P450 2E1, a member of the cytochrome P450 mixed-function oxidase system, is involved in the metabolism of xenobiotics in the body. While it is only involved in the oxidative metabolism of a small range of substrates, there are some important drug interactions mediated by CYP2E1. CYP2E1 - CYP2E1 Ligands. While it is involved only in the oxidative metabolism of a small range of substrates, there are many important drug interactions mediated by CYP2E1.Within one day of birth, the rat hepatic CYP2E1 gene is activated transcriptionally. CYP2E1 expression is easily inducible. It seems that there exist two stages of induction, a posttranslational mechanism for increased protein stability at low levels of ethanol, and an additional transciptional induction at high levels of ethanol.

Reference

"Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme."
J. Biol. Chem. 261:16689-16697(1986) [PubMed] [Europe PMC] [Abstract]

"Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression."
Biochemistry 27:9006-9013(1988) [PubMed] [Europe PMC] [Abstract]

"The DNA sequence and comparative analysis of human chromosome 10."
Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract]

"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]

"Purification and characterization of human liver cytochrome P-450-ALC."
Biochem. Biophys. Res. Commun. 148:232-238(1987) [PubMed] [Europe PMC] [Abstract]

"Human liver cytochrome P-450 related to a rat acetone-inducible, nitrosamine-metabolizing cytochrome P-450: identification and isolation."
Pharmacology 39:137-144(1989) [PubMed] [Europe PMC] [Abstract]

"Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties."
Arch. Biochem. Biophys. 312:59-66(1994) [PubMed] [Europe PMC] [Abstract]

"Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1."
Chem. Res. Toxicol. 10:1205-1212(1997) [PubMed] [Europe PMC] [Abstract]

"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."
J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]

"Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates."
J. Biol. Chem. 283:33698-33707(2008) [PubMed] [Europe PMC] [Abstract]

"Genetic polymorphism of human CYP2E1: characterization of two variant alleles."
Mol. Pharmacol. 51:370-376(1997) [PubMed] [Europe PMC] [Abstract]

"Detection and characterization of novel polymorphisms in the CYP2E1 gene."
Pharmacogenetics 8:543-552(1998) [PubMed] [Europe PMC] [Abstract]

"Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population."
Pharmacogenomics 5:895-931(2004) [PubMed] [Europe PMC] [Abstract]